BRD4 and colonic neoplasm: In primary human colon cancer cells, pCan1 and pCan2, A1874 (100 nM) treatment led to robust degradation of BRD4 protein (Fig. 3a) without affecting BRD4 mRNA expression (Fig. 3b).